FNMA Stock | Buy or Sell? | News | Quote | Stock Forum | Friday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$FNMA Fannie Mae FNMA Company Overview 

FNMA Overall Average: 40% Buy

Stock Message Board http://investorshangout.com/search?q=FNMA&...mp;yt1=Go!

Last Updated: Friday, December 13, 2013 11:16:41 PM

Fannie Mae FNMA Current Price and Quotes
Last Price 2.78
Previous Close 2.75 Open 2.745
Daily Range 2.92 - 2.74 52wk Range 5.44 - 0.25
Volume 29,740,333 Dividend N/A
Average Vol (3m) 25,840,703 Yield N/A
Fannie Mae FNMA
Company Information

3900 Wisconsin Avenue, N.W.
Washington, DC 20016

Website: http://www.fanniemae.com
Phone: 202-752-7000
Email: info@fanniemae.com
Find us on:  

Fannie Mae FNMA
Fannie Mae is a government-sponsored enterprise that was chartered by Congress in 1938 to support liquidity, stability and affordability in the secondary mortgage market, where existing mortgage-related assets are purchased and sold.

Fannie Mae FNMA
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0000310522
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 6111 - Federal and federally sponsored credit
Incorporated In: USA
Year of Inc. Not Available
Employees 6000 a/o Dec 31, 2009
Company Officers/Contacts

Timothy J. Mayopoulous CEO, President
Susan R. McFarland EVP, CFO
Company Directors

Phillip Laskawy Chairman
Robert H. Herz
Company Notes

Formerly=Federal National Mortgage Association until 12-96
Service Providers

Auditor/Accountant
Deloitte & Touche LLP
225 W. Santa Clara St.
San Jose, CA, 95113
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Fannie Mae FNMA
FNMA Security Details Other Company Securities

Share Structure

Market Value1 $3,219,464,226 a/o Dec 13, 2013
Shares Outstanding 1,158,080,657 a/o Sep 30, 2013
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record 14,000 a/o Apr 02, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Jul 29, 2002 Jul 31, 2002 Aug 25, 2002
Security Notes

Capital Change=shs increased by 4 for 1 split. Ex-date=01/16/1996. Rec date=01/08/1996. Pay date=01/12/1996.
Short Selling Data

Short Interest 12,424,817 (23.66%)
Nov 29, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Fannie Mae FNMA Financials

Fannie Mae FNMA Recent News

Dec 13, 2013 Bullish Stocks Radar: Camtek LTD, Performance Technologies, Federal National Mortgage, The Boeing Company
Dec 5, 2013 Free Real-Time Level 2 Quotes Available in Fannie Mae and Freddie Mac at OTCMarkets.com
Dec 4, 2013 Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals
Dec 2, 2013 Sizzling Stocks Buzz: OCZ Technology Group, Federal National Mortgage Association, General Electric Company, Cisco Systems
Nov 27, 2013 Fannie Mae Releases October 2013 Monthly Summary
Nov 22, 2013 Breakfast News: AMR Corporation, Federal National Mortgage Association, Nevada Gold Corp, Buka Ventures Inc
Nov 21, 2013 Notable Stock Buzzers: Federal National Mortgage Association, Augusta Resource Corp, Organovo Holdings Inc, VOXELJET AG
Nov 21, 2013 Signs Point to Economic Volatility in the Near Term
Nov 21, 2013 Stocks Showing Positive Trend: Federal National Mortgage Association, Netflix, Teva Pharmaceutical Industries, Sirius XM Radio, eBay Inc
Nov 18, 2013 FNMA, FMCC, AMMRQ and MJNA added to OTC Active Stock Watch List at EPR

1
2
3
next >
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 198

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 163

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 410

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Globant's 2025 Q1 Revenue Growth and Strategic Focus

Updated Category News Views 873

Globant's Remarkable Financial Performance for Q1 2025 Globant (NYSE: GLOB), a leader in technology-enabled business transformation, has reported a strong performance for the first quarter of 2025. The company achieved revenues of $611.1 million, marking a 7.0% increase compared to the same period last year. This notable growth reflects Globant's commitment to leveraging...

Continue Reading
Transforming Rehabilitation: The Future of Medical Exoskeletons

Updated Category News Views 329

Explosive Growth in the Medical Exoskeleton Market The global medical exoskeleton market is experiencing remarkable growth, projected to reach a value increase of USD 2.87 billion during the upcoming period from 2024 to 2028. A crucial driving force behind this surge is the rising number of spinal cord injury (SCI) cases, coupled with advancements in artificial...

Continue Reading
Exclusive Elks Hoop Shoot Champions Honored at Hall of Fame

Updated Category News Views 167

Celebrating Youth Basketball Talent The spirit of perseverance and hard work was palpable as the finest youth free-throw shooters gathered at Wintrust Arena, illustrating their dedication to the game. Recently, the Elks Hoop Shoot competition showcased young athletes' skills and determination as they vied for national titles in three age groups for both boys and girls....

Continue Reading
Key Insights for Cepton, Inc. Investors Regarding Legal Actions

Updated Category News Views 190

Understanding Your Legal Rights as a Cepton, Inc. Investor Cepton, Inc. (NASDAQ: CPTN) has recently come under scrutiny, attracting the attention of investors concerned about potential securities fraud. As such, it is crucial for shareholders to be informed about their rights and options as they navigate these turbulent waters. Recent developments suggest that investors...

Continue Reading
Teamsters at Seattle Airport Vote to Strike Against Swissport

Updated Category News Views 283

Teamsters at Seattle Airport Take Bold Action In a significant move toward ensuring safe and fair labor practices, air fuelers at Seattle-Tacoma International Airport have voted unanimously to authorize a strike against Swissport, a leading provider of ground services in the aviation industry. With over 150 workers represented by Teamsters Local 174, this decision stems...

Continue Reading